Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
3(20%)
Results Posted
83%(5 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_1
3
20%
Ph not_applicable
3
20%
Ph early_phase_1
1
7%
Ph phase_3
1
7%
Ph phase_2
7
47%

Phase Distribution

4

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
1(6.7%)
Phase 1Safety & dosage
3(20.0%)
Phase 2Efficacy & side effects
7(46.7%)
Phase 3Large-scale testing
1(6.7%)
N/ANon-phased studies
3(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(3)
Completed(6)
Terminated(3)
Other(3)

Detailed Status

Completed6
unknown3
Recruiting3
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (6.7%)
Phase 13 (20.0%)
Phase 27 (46.7%)
Phase 31 (6.7%)
N/A3 (20.0%)

Trials by Status

unknown320%
withdrawn17%
completed640%
terminated213%
recruiting320%

Recent Activity

3 active trials
Showing 5 of 15
recruitingphase_2

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

NCT06388720
completedearly_phase_1

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

NCT01858025
recruitingnot_applicable

Adaptive Radiation in Anal Cancer

NCT05838391
completedphase_2

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

NCT02369458
recruitingphase_1

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

NCT05688488
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06388720Phase 2

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Recruiting
NCT01858025Early Phase 1

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

Completed
NCT05838391Not Applicable

Adaptive Radiation in Anal Cancer

Recruiting
NCT02369458Phase 2

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

Completed
NCT05688488Phase 1

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

Recruiting
NCT02805257Phase 2

Ahmed Glaucoma Valve Surgery With Mitomycin-C

Completed
NCT02030990Phase 2

The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements

Unknown
NCT01324141Phase 1

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

Terminated
NCT02982395Phase 3

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Terminated
NCT00386399Phase 2

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Withdrawn
NCT02016898Phase 2

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

Completed
NCT02989207Not Applicable

Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans

Unknown
NCT01296763Phase 1

Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

Completed
NCT01504282Not Applicable

Mitomycin-c Application for PRK

Completed
NCT01297803Phase 2

Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15